Device Trial Radar · NCT03583957
A Wireless EEG Patch for Continuous Electrographic Monitoring
Last checked: Nov 20, 2026Latest source record: Feb 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
750
Planned (sponsor's estimate)
Start
May 8, 2018
Primary completion
Apr 30, 2026
Study completion Apr 30, 2026
Sponsor
- Lead sponsor
- Epitel, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Boston Children's Hospital; National Institute of Neurological Disorders and Stroke (NINDS); NYU Langone Health; University of Colorado, Denver
- First posted
- Jul 12, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This proposal will evaluate an individual-use, patch-type telemetry device for simplified, single-channel EEG recording from human patients along-side the traditional in hospital wired EEG.
Conditions
- Epilepsy
Interventions
Observational onlyDevice
Device is only observational and used to record EEG.
Psychological and Behavioral interaction with a seizure forecasting mobile appBehavioral
Participants will be interacting with a mobile app to input perceived behavioral (e.g., number of hours slept and sleepiness) and psychological (perceived stress).
Seizure Alerting and Prediction SystemCombination product
The combination of Epilog (device) and the Aura app (psychological and behavioral interaction) will be used to create a real-time seizure alerting and an hourly seizure forecasting system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Single channel EEG coherenceTime frame: Through study completion
- Sensitivity and specificity for retrospect seizure detectionTime frame: Through Phase I completion, 2 years
- Sensitivity and specificity for prospective seizure alertingTime frame: Through study completion, 5 years
1 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado Anschutz Medical Center
Aurora, Colorado
Boston Children's Hospital
Boston, Massachusetts
New York University Langone Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.